Bionano Genomics, Inc (BNGO) insider trading
Every open-market stock purchase and sale by Bionano Genomics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Albert Luderer (CEO) bought $9.7K in the last 90 days, more than doubling their stake.
Last 12 months: insiders bought $9.7K (2 buys) and sold $0 (0 sales). Last close $1.22 on Sep 11, 2026.
Recent BNGO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 4, 2026 | Albert Luderer (CEO) | Bought | $4.8K |
| Aug 21, 2026 | Albert Luderer (CEO) | Bought | $4.9K |
| Aug 3, 2026 | Mark Adamchak (Insider) | Bought (not open market) | — |
| Aug 3, 2026 | Alex Reid Hastie (C-suite exec) | Bought (not open market) | — |
| Aug 3, 2026 | Jonathan V. Dixon (General Counsel) | Bought (not open market) | — |
| Aug 3, 2026 | Mark Oldakowski (COO) | Bought (not open market) | — |
| Jun 3, 2026 | Mark Oldakowski (COO) | Sold (not open market) | $35 |
| Jun 3, 2026 | Jonathan V. Dixon (General Counsel) | Sold (not open market) | $31 |
| Jun 3, 2026 | Alka Chaubey (C-suite exec) | Sold (not open market) | $31 |
| Jun 3, 2026 | Mark Adamchak (Insider) | Sold (not open market) | $9 |
| May 14, 2026 | Kristiina Vuori MD (Insider) | Bought (not open market) | — |
| May 14, 2026 | Aleksandar Rajkovic (Insider) | Bought (not open market) | — |
| May 14, 2026 | David L Barker (Insider) | Bought (not open market) | — |
| May 14, 2026 | Christopher J Twomey (Insider) | Bought (not open market) | — |
| May 14, 2026 | Yvonne Linney (Insider) | Bought (not open market) | — |
| Feb 17, 2026 | R. Erik Holmlin (CEO) | Sold (not open market) | $56 |
| Feb 17, 2026 | Mark Oldakowski (COO) | Sold (not open market) | $22 |
| Feb 17, 2026 | Alka Chaubey (C-suite exec) | Sold (not open market) | $20 |
| Feb 17, 2026 | Jonathan V. Dixon (General Counsel) | Sold (not open market) | $7 |
| Feb 17, 2026 | Mark Adamchak (Insider) | Sold (not open market) | $3 |
| Feb 2, 2026 | R. Erik Holmlin (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Jonathan V. Dixon (General Counsel) | Bought (not open market) | — |
| Feb 2, 2026 | Alka Chaubey (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Mark Adamchak (Insider) | Bought (not open market) | — |
| Feb 2, 2026 | Mark Oldakowski (COO) | Bought (not open market) | — |
Who's trading BNGO
- Albert Luderer, Director: bought $9.7K (2 buys), last Sep 4, 2026
- Mark Adamchak, Officer: other filings, last Aug 3, 2026
- Jonathan V. Dixon, General Counsel: other filings, last Aug 3, 2026
- Alex Reid Hastie, C-suite exec: other filings, last Aug 3, 2026
- Mark Oldakowski, COO: other filings, last Aug 3, 2026
- Alka Chaubey, C-suite exec: other filings, last Jun 3, 2026
- Yvonne Linney, Director: other filings, last May 14, 2026
- David L Barker, Director: other filings, last May 14, 2026
- Aleksandar Rajkovic, Director: other filings, last May 14, 2026
- Christopher J Twomey, Director: other filings, last May 14, 2026
- Kristiina Vuori MD, Director: other filings, last May 14, 2026
- R. Erik Holmlin, CEO: other filings, last Feb 17, 2026
Get free alerts when an insider at Bionano Genomics, Inc files a new trade →